Switch to:

Ascendis Pharma A/S Accumulated Depreciation

: $0.00 Mil (As of Sep. 2019)
View and export this data going back to 2015. Start your Free Trial

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Ascendis Pharma A/S's annual accumulated depreciation increased from Dec. 2016 ($-3.94 Mil) to Dec. 2017 ($-5.02 Mil) and increased from Dec. 2017 ($-5.02 Mil) to Dec. 2018 ($-5.45 Mil).


Ascendis Pharma A/S Accumulated Depreciation Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Ascendis Pharma A/S Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Accumulated Depreciation Premium Member Only Premium Member Only Premium Member Only -3.18 -3.42 -3.94 -5.02 -5.45

Ascendis Pharma A/S Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Accumulated Depreciation Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -5.45 0.00 0.00 0.00

Ascendis Pharma A/S Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.


Ascendis Pharma A/S Accumulated Depreciation Related Terms


Ascendis Pharma A/S Accumulated Depreciation Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)